European Parliament · 23 November 2021

A pharmaceutical strategy for Europe

Amendment

Rejected

This was a vote on one amendment to the text, not on the text as a whole.

148 in favour · 501 against · 16 abstained. 665 members voted.

What it asks for, in the Parliament's words

• Calls on the Commission to support pricing models which take account of real production costs
• Calls on the Commission to promote the development of research in the field of pain therapy drugs
• Calls on the Commission to develop clear guidance on the role of procurement policy in promoting greener pharmaceuticals

Quoted from A9-0317/2021, which says more than these lines. Each is a whole paragraph; this site does not rewrite them.

See how every country and every MEP voted

Check it at the European Parliament

• Roll-call results, 23 November 2021
• Minutes of the sitting
• Open data record for the sitting